Graves MC - Search Results

1

ATR inhibition using gartisertib enhances cell death and synergises with temozolomide and radiation in patient-derived glioblastoma cell lines.

Lozinski M, Bowden NA, Graves MC, Fay M, Day BW, Stringer BW, Tooney PA. Lozinski M, et al. Among authors: graves mc. Oncotarget. 2024 Jan 16;15:1-18. doi: 10.18632/oncotarget.28551. Oncotarget. 2024. PMID: 38227740 Free PMC article.

2

DNA damage repair in glioblastoma: current perspectives on its role in tumour progression, treatment resistance and PIKKing potential therapeutic targets.

Lozinski M, Bowden NA, Graves MC, Fay M, Tooney PA. Lozinski M, et al. Among authors: graves mc. Cell Oncol (Dordr). 2021 Oct;44(5):961-981. doi: 10.1007/s13402-021-00613-0. Epub 2021 May 31. Cell Oncol (Dordr). 2021. PMID: 34057732 Review.

3

Low tumour-infiltrating lymphocyte density in primary and recurrent glioblastoma.

Maddison K, Graves MC, Bowden NA, Fay M, Vilain RE, Faulkner S, Tooney PA. Maddison K, et al. Among authors: graves mc. Oncotarget. 2021 Oct 12;12(21):2177-2187. doi: 10.18632/oncotarget.28069. eCollection 2021 Oct 12. Oncotarget. 2021. PMID: 34676050 Free PMC article.

4

Transcriptomic Profiling of DNA Damage Response in Patient-Derived Glioblastoma Cells before and after Radiation and Temozolomide Treatment.

Lozinski M, Bowden NA, Graves MC, Fay M, Day BW, Stringer BW, Tooney PA. Lozinski M, et al. Among authors: graves mc. Cells. 2022 Apr 4;11(7):1215. doi: 10.3390/cells11071215. Cells. 2022. PMID: 35406779 Free PMC article.

5

Characteristics of vasculogenic mimicry and tumour to endothelial transdifferentiation in human glioblastoma: a systematic review.

Maddison K, Bowden NA, Graves MC, Tooney PA. Maddison K, et al. Among authors: graves mc. BMC Cancer. 2023 Feb 23;23(1):185. doi: 10.1186/s12885-023-10659-y. BMC Cancer. 2023. PMID: 36823554 Free PMC article.

6

Vasculogenic Mimicry Occurs at Low Levels in Primary and Recurrent Glioblastoma.

Maddison K, Faulkner S, Graves MC, Fay M, Bowden NA, Tooney PA. Maddison K, et al. Among authors: graves mc. Cancers (Basel). 2023 Aug 1;15(15):3922. doi: 10.3390/cancers15153922. Cancers (Basel). 2023. PMID: 37568738 Free PMC article.

7

Immune checkpoint blockade in solid organ tumours: Choice, dose and predictors of response.

Navani V, Graves MC, Bowden NA, Van Der Westhuizen A. Navani V, et al. Among authors: graves mc. Br J Clin Pharmacol. 2020 Sep;86(9):1736-1752. doi: 10.1111/bcp.14352. Epub 2020 Jun 5. Br J Clin Pharmacol. 2020. PMID: 32384184 Free PMC article. Review.

8

Monitoring Patient Response to Pembrolizumab With Peripheral Blood Exhaustion Marker Profiles.

Graves M, CelliMarchett G, van Zyl B, Tang D, Vilain RE, van der Westhuizen A, Bowden NA. Graves M, et al. Front Med (Lausanne). 2019 May 22;6:113. doi: 10.3389/fmed.2019.00113. eCollection 2019. Front Med (Lausanne). 2019. PMID: 31192212 Free PMC article.

9

Pilot early phase II study of decitabine and carboplatin in patients with advanced melanoma.

van der Westhuizen A, Knoblauch N, Graves MC, Levy R, Vilain RE, Bowden NA. van der Westhuizen A, et al. Among authors: graves mc. Medicine (Baltimore). 2020 Jun 19;99(25):e20705. doi: 10.1097/MD.0000000000020705. Medicine (Baltimore). 2020. PMID: 32569203 Free PMC article.

10

Melanoma: An immunotherapy journey from bench to bedside.

Navani V, Graves MC, Mandaliya H, Hong M, van der Westhuizen A, Martin J, Bowden NA. Navani V, et al. Among authors: graves mc. Cancer Treat Res. 2022;183:49-89. doi: 10.1007/978-3-030-96376-7_2. Cancer Treat Res. 2022. PMID: 35551656

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters